CVE-2007-1132
Multiple cross-site scripting (XSS) vulnerabilities in the "Contact Us" functionality in MTCMS 2...
Multiple cross-site scripting (XSS) vulnerabilities in the "Contact Us" functionality in MTCMS 2.2 allow remote attackers to inject arbitrary web script or HTML via the (1) message and (2) title fields.
Exploit likelihood
What each source reports
NVD Score used
Multiple cross-site scripting (XSS) vulnerabilities in the "Contact Us" functionality in MTCMS 2.2 allow remote attackers to inject arbitrary web script or HTML via the (1) message and (2) title fields.
- Record
CVE-2007-1132- CVSS 2.0
- 4.3 Medium
AV:N/AC:M/Au:N/C:N/I:P/A:N - Weakness
- CWE-79
- Updated
- 2026-11-02
CVE List No score
Multiple cross-site scripting (XSS) vulnerabilities in the "Contact Us" functionality in MTCMS 2.2 allow remote attackers to inject arbitrary web script or HTML via the (1) message and (2) title fields.
- Record
CVE-2007-1132- Updated
- 2026-11-02
EUVDEUVD-2007-1129 No score
Multiple cross-site scripting (XSS) vulnerabilities in the "Contact Us" functionality in MTCMS 2.2 allow remote attackers to inject arbitrary web script or HTML via the (1) message and (2) title fields.
- Record
EUVD-2007-1129- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-34qf-2gp8-q45p No score
Multiple cross-site scripting (XSS) vulnerabilities in the "Contact Us" functionality in MTCMS 2...
Multiple cross-site scripting (XSS) vulnerabilities in the "Contact Us" functionality in MTCMS 2.2 allow remote attackers to inject arbitrary web script or HTML via the (1) message and (2) title fields.
- Record
GHSA-34qf-2gp8-q45p- Weakness
- CWE-79
- Updated
- 2026-11-02
Affected products
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2007-1132 is a medium vulnerability (CVSS 4.3) in Mtcms, published February 27, 2007. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 1.09%, the 65th percentile. No source names a fixed version.